Physician profile
Jack E Mckay
NPI 1932527942
$35,160.81
in general payments reported to CMS, 2019-2025
10 companies · $1,813 in 2025
The $1,813 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $3,629 · 2022: $2,591 · 2023: $915 · 2024: $5,804 · 2025: $1,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,409 · Food and Beverage: $2,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,408.71 |
| Food and Beverage | $2,123.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,376.78 | 2019-2024 | |
| Smith+Nephew, INC. | $6,758.28 | 2020-2025 | Acufex Meniscal Root Repair, Healicoil, Bone Anchors With Arthroscopic Delivery System |
| Cgg Medical INC | $5,747.83 | 2022-2025 | |
| Stryker Corporation | $914.52 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $145.73 | 2022 | |
| Vericel Corporation | $65.73 | 2023-2025 | Maci |
| Depuy Synthes Sales INC. | $50.60 | 2020-2023 | Va-Lcp |
| Bioventus LLC | $37.49 | 2023-2024 | Durolane, Durolane |
| Orthofix Medical, INC. | $36.85 | 2022-2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $27.00 | 2023 | Zilretta, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Mckay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.